The defined role of CD73 in cervical cancer cells has not been fully established.11–13 Therefore, CD73 acting as a regulator of adenosine production, has been treated as valuable drug target in several conditions such as autoimmunity, cancer, ischemic-reperfusion injury and allergy. This evidence concerns the gene NT5E and cervical cancer.